Finance

Beta
Ask
Lists
ABL:FRA
Abbott Laboratories
77,84 €
+0,49%
(+0,38) 1D
17 ივნ, 22:00:00 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for ABL...
Open
77,82 €
High
78,38 €
Low
77,82 €
Mkt. cap
154,15 მლრ.
Avg. vol.
339,00
Volume
80,00
52-wk high
118,58 €
52-wk low
69,76 €
No. of employees
115 ათ.
Open
77,82 €
High
78,38 €
Low
77,82 €
Mkt. cap
154,15 მლრ.
Avg. vol.
339,00
Volume
80,00
52-wk high
118,58 €
52-wk low
69,76 €
No. of employees
115 ათ.
News stories
From sources across the web
AD HOC NEWS
AD HOC NEWS
·
12 საათის წინ
Abbott Laboratories Stock - analyst views and operations midyear
GuruFocus
GuruFocus
·
17 საათის წინ
Abbott (ABT) Share Value Potential Estimated at $99-$104 by Citi
TipRanks
TipRanks
·
17 საათის წინ
Citi sum-of-the-parts analysis shows Abbott share upside
AOL.com
AOL.com
·
1 დღის წინ
AbbVie Stock Will Hit $300 on This Date
Profile
Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company founded in Chicago with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices. Abbott operates in over 160 countries and sources from at least 62 suppliers worldwide. Abbott's products include Pedialyte, Similac, BinaxNOW, Ensure, Glucerna, ZonePerfect, FreeStyle Libre, i-STAT and MitraClip. The company is ranked 107th on the Fortune 500 and 144th on the Forbes Global 2000. Wikipedia
About Abbott Laboratories
CEOრობერ ბი ფორდ
Employees115 ათ.
Founded1888
Headquartersჩიკაგო, ილინოისი, ამერიკის შეერთებული შტატები
SectorMedical device
Websiteabbott.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
ივნ. 2025
სექ. 2025
დეკ. 2025
მარ. 2026
Revenue
11,14 მლრდ.
11,37 მლრდ.
11,46 მლრდ.
11,16 მლრდ.
Cost of goods sold
4,85 მლრდ.
5,08 მლრდ.
4,91 მლრდ.
4,89 მლრდ.
Cost of revenue
4,85 მლრდ.
5,08 მლრდ.
4,91 მლრდ.
4,89 მლრდ.
Research and development expenses
725,00 მლნ.
766,00 მლნ.
720,00 მლნ.
767,00 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,94 მლრდ.
2,90 მლრდ.
2,93 მლრდ.
3,58 მლრდ.
Operating expense
4,09 მლრდ.
4,09 მლრდ.
4,07 მლრდ.
4,77 მლრდ.
Total operating expenses
8,94 მლრდ.
9,16 მლრდ.
8,98 მლრდ.
9,66 მლრდ.
Operating income
2,20 მლრდ.
2,20 მლრდ.
2,48 მლრდ.
1,50 მლრდ.
Other non operating income
-9,00 მლნ.
2,00 მლნ.
-15,00 მლნ.
-
EBT including unusual items
2,15 მლრდ.
2,18 მლრდ.
2,36 მლრდ.
1,45 მლრდ.
EBT excluding unusual items
2,15 მლრდ.
2,18 მლრდ.
2,44 მლრდ.
1,45 მლრდ.
Income tax expense
371,00 მლნ.
536,00 მლნ.
582,00 მლნ.
372,00 მლნ.
Effective tax rate
17,26%
24,59%
24,68%
25,67%
Other operating expenses
-
-
-
-
Net income
1,78 მლრდ.
1,64 მლრდ.
1,78 მლრდ.
1,08 მლრდ.
Net profit margin
15,97%
14,46%
15,50%
9,65%
Earnings per share
1,26
1,30
1,50
1,15
Interest and investment income
71,00 მლნ.
77,00 მლნ.
78,00 მლნ.
106,00 მლნ.
Interest expense
-121,00 მლნ.
-121,00 მლნ.
-120,00 მლნ.
-174,00 მლნ.
Net interest expenses
-50,00 მლნ.
-44,00 მლნ.
-42,00 მლნ.
-68,00 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
2,98 მლრდ.
3,00 მლრდ.
3,27 მლრდ.
2,31 მლრდ.
Gain or loss from assets sale
-
-
65,00 მლნ.
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer